Terbinafine hydrochloride
Purpose
Antifungal
Uses
- cures most athlete’s foot (tinea pedis)
- cures most jock itch (tinea cruris) and ringworm (tinea corporis)
- relieves itching, burning, cracking and scaling which accompany these conditions
Warnings
For external use only
Do Not Use
- on nails or scalp
- in or near the mouth or eyes
- for vaginal yeast infections
When using this product
do not get into eyes. If eye contact occurs, rinse thoroughly with water.
Stop use and ask doctor
if too much irritation occurs or gets worse
Keep out of reach of children
If swallowed, get medical help or contact a poison control center right away.
Directions
• adults and children 12 years and over:
• use the tip of the cap to break the seal and open the tube
• wash the affected skin with soap and water and dry completely before applying
• for athlete’s foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily
• between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor
1 week between the toes
• on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor
2 weeks on the bottom or sides of the foot
• for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor
• wash hands after each use
• children under 12 years: ask a doctor
Other information
- do not use if seal on tube is broken or is not visible
- store at controlled room temperature 20-25°C (68-77°F)
Inactive ingredients
benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.
Questions
call 1-800-452-0051
Novartis Consumer Health, Inc.
Parsippany, NJ 07054-0622 ©2008
Principal display panel
Lamisil AT Cream
LAMISIL AT terbinafine hydrochloride cream | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA020980 | 08/10/2005 |
Labeler - Novartis Consumer Health, Inc. (879821635) |
More Lamisil AT Cream resources
- Lamisil AT Cream Side Effects (in more detail)
- Lamisil AT Cream Use in Pregnancy & Breastfeeding
- Lamisil AT Cream Support Group
- 4 Reviews for Lamisil AT - Add your own review/rating
Compare Lamisil AT Cream with other medications
- Tinea Corporis
- Tinea Cruris
- Tinea Pedis
No comments:
Post a Comment